These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 10882875)
21. Prostate biopsy: who, how and when. An update. Djavan B; Milani S; Remzi M Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165 [TBL] [Abstract][Full Text] [Related]
22. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025 [TBL] [Abstract][Full Text] [Related]
23. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml. Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854 [TBL] [Abstract][Full Text] [Related]
24. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases. Kang SH; Bae JH; Park HS; Yoon DK; Moon DG; Kim JJ; Cheon J Int J Urol; 2006 Jul; 13(7):910-4. PubMed ID: 16882054 [TBL] [Abstract][Full Text] [Related]
25. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial. Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156 [TBL] [Abstract][Full Text] [Related]
26. Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng./ml or less. Noldus J; Stamey TA J Urol; 1996 Feb; 155(2):441-3. PubMed ID: 8558630 [TBL] [Abstract][Full Text] [Related]
27. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml]. Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752 [TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features. Krumholtz JS; Carvalhal GF; Ramos CG; Smith DS; Thorson P; Yan Y; Humphrey PA; Roehl KA; Catalona WJ Urology; 2002 Sep; 60(3):469-73; discussion 473-4. PubMed ID: 12350486 [TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer. Moon DG; Cheon J; Kim JJ; Yoon DK; Koh SK Int J Urol; 1999 Sep; 6(9):455-62. PubMed ID: 10510891 [TBL] [Abstract][Full Text] [Related]
30. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL. Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929 [TBL] [Abstract][Full Text] [Related]
31. Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years. Postma R; de Vries SH; Roobol MJ; Wildhagen MF; Schröder FH; van der Kwast TH Cancer; 2005 Feb; 103(4):708-16. PubMed ID: 15648082 [TBL] [Abstract][Full Text] [Related]
32. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination. Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149 [TBL] [Abstract][Full Text] [Related]
33. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff. Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H; Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671 [TBL] [Abstract][Full Text] [Related]
34. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml. Raaijmakers R; de Vries SH; Blijenberg BG; Wildhagen MF; Postma R; Bangma CH; Darte C; Schröder FH Eur Urol; 2007 Nov; 52(5):1358-64. PubMed ID: 17499425 [TBL] [Abstract][Full Text] [Related]
35. Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study. Reissigl A; Pointner J; Horninger W; Ennemoser O; Strasser H; Klocker H; Bartsch G Urology; 1995 Nov; 46(5):662-5. PubMed ID: 7495117 [TBL] [Abstract][Full Text] [Related]
36. Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study. Rietbergen JB; Kranse R; Hoedemaeker RF; Kruger AE; Bangma CH; Kirkels WJ; Schröder FH Urology; 1998 Aug; 52(2):237-46. PubMed ID: 9697788 [TBL] [Abstract][Full Text] [Related]
37. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination. Leewansangtong S; Tantiwong A; Ratanarapee S; Nualyong C; Soontrapa S J Med Assoc Thai; 2000 Dec; 83(12):1519-24. PubMed ID: 11253893 [TBL] [Abstract][Full Text] [Related]
38. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712 [TBL] [Abstract][Full Text] [Related]
39. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. Catalona WJ; Richie JP; deKernion JB; Ahmann FR; Ratliff TL; Dalkin BL; Kavoussi LR; MacFarlane MT; Southwick PC J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994 [TBL] [Abstract][Full Text] [Related]
40. Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. Aleman M; Karakiewicz PI; Kupelian P; Kattan MW; Graefen M; Cagiannos I; Eastham J; Scardino PT; Huland H; Klein EA Urology; 2003 Jul; 62(1):70-4. PubMed ID: 12837425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]